|
39
|
121
|
1zyxA |
Crystal structure of the complex of a group iia phospholipase a2 with a synthetic anti-inflammatory agent licofelone at 1.9a resolution |
|
43
|
122
|
1zl7A |
Crystal structure of catalytically-active phospholipase a2 with bound calcium |
|
37
|
119
|
1yxhA |
Crystal structure of a novel phospholipase a2 from naja naja sagittifera with a strong anticoagulant activity |
|
37
|
119
|
1yxlA |
Crystal structure of a novel phospholipase a2 from naja naja sagittifera at 1.5 a resolution |
|
33
|
122
|
1z76A |
Crystal structure of an acidic phospholipase a2 (btha-i) from bothrops jararacussu venom complexed with p-bromophenacyl bromide |
|
35
|
118
|
1y75B |
A new form of catalytically inactive phospholipase a2 with an unusual disulphide bridge cys 32- cys 49 reveals recognition for n-acetylglucosmine |
|
41
|
121
|
1y4lA |
Crystal structure of bothrops asper myotoxin ii complexed with the anti-trypanosomal drug suramin |
|
45
|
131
|
1y6oA |
Crystal structure of disulfide engineered porcine pancreatic phospholipase a2 to group-x isozyme in complex with inhibitor mj33 and phosphate ions |
|
37
|
118
|
1y75A |
A new form of catalytically inactive phospholipase a2 with an unusual disulphide bridge cys 32- cys 49 reveals recognition for n-acetylglucosmine |
|
41
|
121
|
1y38A |
Crystal structure of the complex formed between phospholipase a2 dimer and glycerophosphate at 2.4 a resolution |
|
43
|
131
|
1y6pA |
Crystal structure of disulfide engineered porcine pancratic phospholipase a2 to group-x isozyme |
|
36
|
119
|
1xxwA |
Structure of zinc induced heterodimer of two calcium free isoforms of phospholipase a2 from naja naja sagittifera at 2.7a resolution |
|
45
|
122
|
1xxsA |
Structural insights for fatty acid binding in a lys49 phospholipase a2: crystal structure of myotoxin ii from bothrops moojeni complexed with stearic acid |
|
35
|
119
|
1xxwB |
Structure of zinc induced heterodimer of two calcium free isoforms of phospholipase a2 from naja naja sagittifera at 2.7a resolution |
|
42
|
123
|
1vl9A |
Atomic resolution (0.97a) structure of the triple mutant (k53,56,121m) of bovine pancreatic phospholipase a2 |
|
45
|
122
|
1vpiA |
Phospholipase a2 inhibitor from vipoxin |
|
39
|
123
|
1vapA |
The monomeric asp49 secretory phospholipase a2 from the venom of agkistridon piscivorus piscivorus |
|
39
|
123
|
1vkqA |
A re-determination of the structure of the triple mutant (k53,56,120m) of phospholipase a2 at 1.6a resolution using sulphur-sas at 1.54a wavelength |
|
39
|
121
|
1vipA |
Anticoagulant class ii phospholipase a2 from the venom of vipera russelli russelli |
|
41
|
123
|
1uneA |
Carboxylic ester hydrolase, 1.5 angstrom orthorhombic form of the bovine recombinant pla2 |
|
46
|
122
|
1umvX |
Crystal structure of an acidic, non-myotoxic phospholipase a2 from the venom of bothrops jararacussu |
|
40
|
118
|
1u4jA |
Crystal structure of a carbohydrate induced dimer of group i phospholipase a2 from bungarus caeruleus at 2.1 a resolution |
|
40
|
122
|
1u73A |
Crystal structure of a dimeric acidic platelet aggregation inhibitor and hypotensive phospholipase a2 from bothrops jararacussu |
|
41
|
121
|
1tk4A |
Crystal structure of russells viper phospholipase a2 in complex with a specifically designed tetrapeptide ala-ile-arg-ser at 1.1 a resolution |
|
39
|
121
|
1tgmA |
Crystal structure of a complex formed between group ii phospholipase a2 and aspirin at 1.86 a resolution |
|
38
|
121
|
1tp2A |
Crystal structure of the complex of group ii phospholipasea2 dimer with a fatty acid tridecanoic acid at 2.4 a resolution |
|
41
|
121
|
1th6A |
Crystal structure of phospholipase a2 in complex with atropine at 1.23a resolution |
|
41
|
121
|
1tj9A |
Structure of the complexed formed between group ii phospholipase a2 and a rationally designed tetra peptide,val-ala-arg-ser at 1.1a resolution |
|
41
|
121
|
1tdvA |
Non-specific binding to phospholipase a2:crystal structure of the complex of pla2 with a designed peptide tyr-trp-ala-ala-ala-ala at 1.7a resolution |
|
42
|
121
|
1tjkA |
Crystal structure of the complex formed between group ii phospholipase a2 with a designed pentapeptide, phe- leu- ser- thr- lys at 1.2 a resolution |
|
41
|
121
|
1tg1A |
Crystal structure of the complex formed between russells viper phospholipase a2 and a designed peptide inhibitor phq-leu-val-arg-tyr at 1.2a resolution |
|
39
|
121
|
1tg4A |
Design of specific inhibitors of groupii phospholipase a2(pla2): crystal structure of the complex formed between russells viper pla2 and designed peptide phe-leu-ala-tyr-lys at 1.7a resolution |
|
36
|
119
|
1td7A |
Interactions of a specific non-steroidal anti-inflammatory drug (nsaid) with group i phospholipase a2 (pla2): crystal structure of the complex formed between pla2 and niflumic acid at 2.5 a resolution |
|
41
|
121
|
1sv3A |
Structure of the complex formed between phospholipase a2 and 4-methoxybenzoic acid at 1.3a resolution. |
|
38
|
118
|
1tc8A |
Crystal structure of krait-venom phospholipase a2 in a complex with a natural fatty acid tridecanoic acid |
|
37
|
121
|
1sv9A |
Crystal structure of the complex formed between groupii phospholipase a2 and anti-inflammatory agent 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid at 2.7a resolution |
|
39
|
119
|
1sz8A |
Crystal structure of an acidic phospholipase a2 from naja naja sagittifera at 1.5 a resolution |
|
42
|
121
|
1sxkA |
Crystal structure of a complex formed between phospholipase a2 and a non-specific anti-inflammatory amino salicylic acid at 1.2 a resolution |
|
38
|
119
|
1t37A |
Design of specific inhibitors of phospholipase a2: crystal structure of the complex formed between group i phospholipase a2 and a designed pentapeptide leu-ala-ile-tyr-ser at 2.6a resolution |
|
43
|
121
|
1sqzA |
Design of specific inhibitors of phopholipase a2: crystal structure of the complex formed between group ii phopholipase a2 and a designed peptide dehydro-ile-ala-arg-ser at 1.2a resolution |
|
39
|
119
|
1s6bB |
X-ray crystal structure of a complex formed between two homologous isoforms of phospholipase a2 from naja naja sagittifera: principle of molecular association and inactivation |
|
42
|
121
|
1skgA |
Structure-based rational drug design: crystal structure of the complex formed between phospholipase a2 and a pentapeptide val-ala-phe-arg-ser |
|
42
|
121
|
1s8hA |
Crystal structure of lys49-phospholipase a2 from agkistrodon contortrix laticinctus, first fatty acid free form |
|
41
|
119
|
1s6bA |
X-ray crystal structure of a complex formed between two homologous isoforms of phospholipase a2 from naja naja sagittifera: principle of molecular association and inactivation |
|
26
|
124
|
1sfvA |
Porcine pancreas phospholipase a2, nmr, minimized average structure |
|
24
|
124
|
1sfwA |
Porcine pancreas phospholipase a2, nmr, 18 structures |
|
46
|
121
|
1s8gA |
Crystal structure of lys49-phospholipase a2 from agkistrodon contortrix laticinctus, fatty acid bound form |
|
37
|
121
|
1s8iA |
Crystal structure of lys49-phospholipase a2 from agkistrodon contortrix laticinctus, second fatty acid free form |
|
29
|
122
|
1rgbA |
Phospholipase a2 from vipera ammodytes meridionalis |
|
41
|
121
|
1qllA |
Piratoxin-ii (prtx-ii) - a k49 pla2 from bothrops pirajai |
